Stimulation of Id1 expression by bone morphogenetic protein is sufficient and necessary for bone morphogenetic protein-induced activation of endothelial cells

Circulation

Volumn 106, Issue 17, 2002, Pages 2263-2270

  Valdimarsdottir, Gudrun ^a   Goumans, Marie José ^a   Rosendahl, Alexander ^a   Brugman, Martijn ^a   Itoh, Susumu ^a   Lebrin, Franck ^a   Sideras, Paschalis ^a   Ten Dijke, Peter ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Angiogenesis; Growth substances; Signal transduction

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN RECEPTOR; CELL PROTEIN; INHIBITOR OF DIFFERENTIATION 1; PROTEIN SERINE THREONINE KINASE; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

ANIMALS; BONE MORPHOGENETIC PROTEIN RECEPTORS; BONE MORPHOGENETIC PROTEINS; CATTLE; CELL MOVEMENT; CELLS, CULTURED; DNA-BINDING PROTEINS; ENDOTHELIUM, VASCULAR; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEIN 1; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHOPROTEINS; PHOSPHORYLATION; RECEPTORS, CELL SURFACE; RECEPTORS, GROWTH FACTOR; REPRESSOR PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; SMAD5 PROTEIN; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 0037159280     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000033830.36431.46     Document Type: Article

References (23)

1. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med. 2000;6:389-395.
2. Massagué J. How cells read TGF-β signals. Nat Rev Mol Cell Biol. 2000;1:169-178.
3. Schluesener HJ, Meyermann R. Immunolocalization of BMP-6, a novel TGF-β-related cytokine, in normal and atherosclerotic smooth muscle cells. Atherosclerosis 1995;113:153-156.
4. Willette RN, Gu JL, Lysko PG. et al. BMP-2 gene expression and effects on human vascular smooth muscle cells. J Vasc Res. 1999;36:120-125.
5. Glienke J. Schmitt AO, Pilarsky C, et al. Differential gene expression by endothelial cells in distinct angiogenic states. Eur J Biochem. 2000;267:2820-2830.
6. Nakaoka T, Gonda K, Ogita T, et al. Inhibition of rat vascular smooth muscle proliferation in vitro and in vivo by bone morphogenetic protein-2. J Clin Invest. 1997;100:2824-2832.
7. Kawabata M, Imamura T, Miyazono K. Signal transduction by bone morphogenetic proteins. Cytokine Growth Factor Rev. 1998;9:49-61.
8. Goumans M-J, Mummery C. Functional analysis of the TGFβ receptor/Smad pathway through gene ablation in mice. Int J Dev Biol. 2000;44:253-265.
9. Yi SE, LaPolt PS, Yoon BS, et al. The type I BMP receptor BmprIB is essential for female reproductive function. Proc Natl Acad Sci U S A. 2001;98:7994-7999.
10. Gaussin V, van de Putte T, Mishina Y, et al. Endocardial cushion and myocardial defect after cardiac myocyte-specific conditional deletion of the bone morphogenetic protein receptor ALK3. Proc Natl Acad Sci U S A. 2002;99:2878-2883.
11. Lechleider RJ, Ryan JL, Garrett L, et al. Targeted mutagenesis of Smad1 reveals an essential role in chorioallantoic fusion. Dev Biol. 2001;240:157-167.
12. Tremblay KD, Dunn NR, Robertson EJ. Mouse embryos lacking Smad1 signals display defects in extra-embryonic tissues and germ cell formation. Development. 2001;128:3609-3621.
13. de Caestecker M, Meyrick B. Bone morphogenetic proteins, genetics and the pathophysiology of primary pulmonary hypertension. Respir Res. 2001;2:193-197.
14. Rosenzweig BL, Imamura T, Okadome T, et al. Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc Natl Acad Sci U S A. 1995;92:7632-7636.
15. Tamaki K, Souchelnytskyi S, Itoh S, et al. Intracellular signaling of osteogenic protein-1 through Smad5 activation. J Cell Physiol. 1998;177:355-363.
16. Persson U, Izumi H, Souchelnytskyi S, et al. The L45 loop in type I receptors for TGF-β family members is a critical determinant in specifying Smad isoform activation. FEBS Lett. 1998;434:83-87.
17. Goumans M-J, Valdimarsdottir G, Rosendahl A, et al. Balancing the activation state of the endothelium via two distinct TGF-β type I receptors. EMBO J. 2002;20:1743-1753.
18. Rosendahl A, Checchin D, Fehniger TE, et al. Activation of the TGF-β/activin-Smad2 pathway during allergic airway inflammation. Am J Respir Cell Mol Biol. 2001;25:60-68.
19. Hollnagel A, Oehlmann V, Heymer J, et al. Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells. J Biol Chem. 1999;274:19838-19845.
20. Benezra R, Rafii S, Lyden D. The Id proteins and angiogenesis. Oncogene. 2001;20:8334-8341.
21. Lyden D, Young AZ, Zagzag D, et al. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of turnout xenografts. Nature. 1999;401:670-677.
22. Gerber HP, Ferrara N. Angiogenesis and bone growth. Trends Cardiovasc Med. 2000;10:223-228.
23. Deckers MM, van Bezooijen RL, van der Horst G, et al. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology. 2002;143:1545-1553.